The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma

I. A. Zarembo (Saint-Petersburg, Russia)

Source: Annual Congress 2001 - Clinical asthma: miscellaneous
Session: Clinical asthma: miscellaneous
Session type: Thematic Poster Session
Number: 2861
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. A. Zarembo (Saint-Petersburg, Russia). The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma. Eur Respir J 2001; 16: Suppl. 31, 2861

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effectiveness and safety of pre-hospital nebulizer therapy of elderly patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 503s
Year: 2002

Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


The effectiveness of fluconazol application in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 543s
Year: 2004

Efficacy of the long-term therapy with simbicort in children with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005

Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


Efficacy of symbicort administration in patients with bronchial asthma
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009


Neuroregulatorial therapy of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 55s
Year: 2002

Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Cost-effectiveness of budesonid/formoterol inhaler in treatment of moderate bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001

Cost effectiveness of bronchial thermoplasty for treatment of severe asthma patients in spain
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017

A new budesonide/formoterol inhalation therapy in patients with asthma, COPD and ACOS
Source: International Congress 2017 – Bronchial asthma management
Year: 2017

The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 21s
Year: 2003

Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients
Source: Eur Respir J 2002; 20: Suppl. 38, 304s
Year: 2002

Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007

Evaluation of adherence of patients with asthma to treatment by single combination inhaler
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

Efficacy and safety of long-term therapy with Salamol combined with Beclason versus Salamol only in patients with mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002